Home › Forums › Checkpoint Pathway › Immunotherapies

    • Forum
    • Topics
    • Posts
    • Last Post
    • Ipi/Nivo – Ipilimumab plus Nivolumab combination
      Nivolumab (Opdivo) is a checkpoint inhibitor it blocks the activity of a molecule called PD-1 Ipilimumab (Yervoy) is a checkpoint inhibitor it blocks the activity of a molecule called CTLA-4. T Cells have both of these checkpoints inhibitors on their surface and these two immunotherapy drugs are used in combination and also on their own as "monotherapies"
    • 0
    • 0
    • No Topics

    • Keytruda
      A space to discuss Keytruda immunotherapy for the checkpoint pathway. Include on and off trial discussions
    • 0
    • 0
    • No Topics

  •  

  • You must be logged in to create new topics.